Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study

Published:2015-04-14 Issue:1 Volume:16 Page:54-59
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Crona D J,Ramirez J,Qiao W,de Graan A-J,Ratain M J,van Schaik R H N,Mathijssen R H J,Rosner G L,Innocenti F

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201523.pdf

Reference38 articles.

1. Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004; 22: 1382–1388.

2. Kim TW, Innocenti F . Insights, challenges, and future directions in irinogenetics. Ther Drug Monit 2007; 29: 265–270.

3. Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, McLeod HL . UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst 2007; 99: 1290–1295.

4. Beutler E, Gelbart T, Demina A . Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95: 8170–8174.

5. Ramirez J, Mirkov S, Zhang W, Chen P, Das S, Liu W et al. Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver. Pharmacogenomics J 2008; 8: 152–161.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model;Clinical Pharmacology & Therapeutics;2024-02-12

2. Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1;Clinical Pharmacokinetics;2023-09-16

3. Incidence and non-genetic risk factors of irinotecan-induced severe neutropenia in Chinese adult inpatients;Medicine;2023-03-03

4. Revisiting UGT1A1 Pharmacogenetic Testing Before Irinotecan—Why Not?;JCO Oncology Practice;2022-04

5. UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients;European Journal of Cancer;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3